Discovery of Cisplatin-binding Proteins by Competitive Cysteinome Profiling
Overview
Overview
Journal
RSC Chem Biol
Publisher
Royal Society of Chemistry
Specialty
Biology
Date
2023 Sep 1
PMID
37654507
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Cisplatin is a widely used cancer metallodrug that induces cytotoxicity by targeting DNA and chelating cysteines in proteins. Here we applied a competitive activity-based protein profiling strategy to identify cisplatin-binding cysteines in cancer proteomes. A novel cisplatin target, MetAP1, was identified and functionally validated to contribute to cisplatin's cytotoxicity.
References
1.
Ur Rehman N, Khan A, Al-Harrasi A, Khiat M, Hussain H, Wadood A
. Natural urease inhibitors from Aloe vera resin and Lycium shawii and their structural-activity relationship and molecular docking study. Bioorg Chem. 2019; 88:102955.
DOI: 10.1016/j.bioorg.2019.102955.
View
2.
Jonckheere V, Fijalkowska D, Van Damme P
. Omics Assisted N-terminal Proteoform and Protein Expression Profiling On Methionine Aminopeptidase 1 (MetAP1) Deletion. Mol Cell Proteomics. 2018; 17(4):694-708.
PMC: 5880116.
DOI: 10.1074/mcp.RA117.000360.
View
3.
Banci L, Bertini I, Blazevits O, Calderone V, Cantini F, Mao J
. Interaction of cisplatin with human superoxide dismutase. J Am Chem Soc. 2012; 134(16):7009-14.
DOI: 10.1021/ja211591n.
View
4.
Cunningham R, DeRose V
. Platinum Binds Proteins in the Endoplasmic Reticulum of S. cerevisiae and Induces Endoplasmic Reticulum Stress. ACS Chem Biol. 2017; 12(11):2737-2745.
DOI: 10.1021/acschembio.7b00553.
View
5.
Bernier S, Taghizadeh N, Thompson C, Westlin W, Hannig G
. Methionine aminopeptidases type I and type II are essential to control cell proliferation. J Cell Biochem. 2005; 95(6):1191-203.
DOI: 10.1002/jcb.20493.
View